Halozyme Therapeutics, Inc. (HALO)
62.21
+0.31
(+0.50%)
USD |
NASDAQ |
Dec 12, 16:00
62.21
0.00 (0.00%)
After-Hours: 20:00
Halozyme Therapeutics Gross Profit (TTM): 979.74M for Sept. 30, 2025
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Merck & Co., Inc. | 48.44B |
| ANI Pharmaceuticals, Inc. | 414.16M |
| Bristol Myers Squibb Co. | 30.90B |
| Johnson & Johnson | 62.91B |
| AIM ImmunoTech, Inc. | -0.214M |